Chronic Stroke Survivors Demonstrate Long-Term Improvement in Motor Impairment with Vivistim Therapy
- MicroTransponder, Inc. Announced on May 7, 2025, in Austin, Texas, that a 1-year follow-up study validates Vivistim Paired VNS Therapy for chronic stroke recovery.
- The study responds to limited treatment options for ischemic stroke survivors with upper limb motor impairment by demonstrating long-term therapeutic benefits.
- This landmark, multicenter, triple-blind randomized controlled trial demonstrated that paired vagus nerve stimulation leads to sustained improvements in motor abilities, daily functioning, social involvement, and overall well-being for stroke survivors for a minimum of one year following therapy completion.
- Participants experienced an average increase of 5.23 points on the Fugl-Meyer Assessment Upper Extremity, and no significant negative effects associated with the therapy or stimulation were reported.
- These results confirm that Vivistim, an FDA-cleared and evidence-backed treatment, enables individuals recovering from chronic ischemic stroke to achieve two to threefold greater improvements in upper limb function compared to conventional therapy alone.
Insights by Ground AI
Does this summary seem wrong?
17 Articles
17 Articles
All
Left
1
Center
4
Right

+14 Reposted by 14 other sources
Chronic Stroke Survivors Demonstrate Long-Term Improvement in Motor Impairment with Vivistim Therapy
A 1-Year Follow-Up Study Published in the Peer-Reviewed Journal Stroke Validates Effectiveness of Paired Vagus Nerve Stimulation Therapy for Improved Upper Limb Function
·Parsons, United States
Read Full ArticleAdvances in brain-computer interface controlled functional electrical stimulation for upper limb recovery after stroke
Stroke often results in varying degrees of functional impairment, significantly affecting patients' quality of daily life. In recent years, brain-comp…
·Amsterdam, Netherlands
Read Full ArticleCoverage Details
Total News Sources17
Leaning Left1Leaning Right0Center4Last UpdatedBias Distribution80% Center
Bias Distribution
- 80% of the sources are Center
80% Center
L 20%
C 80%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage